Table 1.
Patient no. | Age (year) | Sex | WAIS-R, WAIS-III, WISC-III | RBMT | Diagnosis at the time of the accident | Period after injury (month) | Main symptoms | |||
---|---|---|---|---|---|---|---|---|---|---|
FIQ | VIQ | PIQ | FMZ | IMZ | ||||||
1 | 28 | M | 98 | 105 | 90 | 21 | No definite abnormalities | 10 | 10 | Irritability, poor concentration |
2 | 51 | M | 100 | 99 | 100 | 20 | Cerebral contusion | 17 | 32 | Difficulty of calculation |
3 | 39 | M | 104 | 111 | 94 | 16 | No definite abnormalities | 4 | 10 | Memory disorder |
4 | 16 | M | 75 | 92 | 66 | 22 | No definite abnormalities | 2 | 13 | Memory disorder |
5 | 21 | M | 90 | 98 | 105 | 17 | Cerebral contusion | 2 | 6 | Mental fatigue |
6 | 28 | F | 85 | 84 | 90 | 23 | Traumatic SAH, DAI, contusion | 4 | 39 | Memory disorder |
7 | 29 | F | 106 | 101 | 101 | 22 | ASDH | 3 | 14 | Mental fatigue |
M male, F female, WAIS-R Wechsler Adult Intelligence Scale-Revised, WAIS-III Wechsler Adult Intelligence Scale-III, WISC-III Wechsler Intelligence Scale for Children-III, FIQ full intelligence quotient, VIQ verbal intelligence quotient, PIQ performance intelligence quotient, RBMT Rivermead Behavioral Memory Test, SAH subarachnoid hemorrhage, DAI diffuse axonal injury, ASDH acute subdural hematoma, FMZ C-11 flumazenil, IMZ I-123 iomazenil